| Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ... Nature biotechnology 31 (6), 539-544, 2013 | 1208 | 2013 |
| The evolving concept of cancer and metastasis stem cells I Baccelli, A Trumpp Journal of Cell Biology 198 (3), 281-293, 2012 | 525 | 2012 |
| Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia I Baccelli, Y Gareau, B Lehnertz, S Gingras, JF Spinella, S Corneau, ... Cancer cell 36 (1), 84-99. e8, 2019 | 221 | 2019 |
| The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias VP Lavallée, I Baccelli, J Krosl, B Wilhelm, F Barabé, P Gendron, ... Nature genetics 47 (9), 1030-1037, 2015 | 173 | 2015 |
| The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer M Wallwiener, AD Hartkopf, I Baccelli, S Riethdorf, S Schott, K Pantel, ... Breast cancer research and treatment 137 (2), 503-510, 2013 | 137 | 2013 |
| Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients I Baccelli, A Stenzinger, V Vogel, BM Pfitzner, C Klein, M Wallwiener, ... Oncotarget 5 (18), 8147, 2014 | 95 | 2014 |
| Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients M Wallwiener, S Riethdorf, AD Hartkopf, C Modugno, J Nees, ... BMC cancer 14, 1-12, 2014 | 89 | 2014 |
| Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy T Hofner, S Macher-Goeppinger, C Klein, A Schillert, C Eisen, S Wagner, ... Urologic Oncology: Seminars and Original Investigations 32 (5), 678-686, 2014 | 58 | 2014 |
| Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic acid–induced 2 S Werner, B Brors, J Eick, E Marques, V Pogenberg, A Parret, D Kemming, ... Cancer discovery 5 (5), 506-519, 2015 | 57 | 2015 |
| Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity L Simon, VP Lavallée, ME Bordeleau, J Krosl, I Baccelli, G Boucher, ... Clinical cancer research 23 (22), 6969-6981, 2017 | 51 | 2017 |
| Pten loss in the bone marrow leads to G-CSF–mediated HSC mobilization M Tesio, GM Oser, I Baccelli, W Blanco-Bose, H Wu, JR Göthert, ... Journal of Experimental Medicine 210 (11), 2337-2349, 2013 | 51 | 2013 |
| Defined conditions for the isolation and expansion of basal prostate progenitor cells of mouse and human origin T Höfner, C Eisen, C Klein, T Rigo-Watermeier, SM Goeppinger, A Jauch, ... Stem cell reports 4 (3), 503-518, 2015 | 32 | 2015 |
| CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy M Drouin, J Saenz, V Gauttier, B Evrard, G Teppaz, S Pengam, C Mary, ... Science Advances 8 (42), eabo7621, 2022 | 19 | 2022 |
| A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens I Baccelli, J Krosl, G Boucher, I Boivin, VP Lavallée, J Hébert, S Lemieux, ... Blood cancer journal 7 (2), e529-e529, 2017 | 19 | 2017 |
| First-in-human study in healthy subjects with the noncytotoxic monoclonal antibody OSE-127, a strict antagonist of IL-7Rα N Poirier, I Baccelli, L Belarif, R Abès, G Teppaz, C Mary, S Poli, ... The Journal of Immunology 210 (6), 753-763, 2023 | 6 | 2023 |
| Effects of essential amino acid deficiency: down‐regulation of KCC2 and the GABAA receptor; disinhibition in the anterior piriform cortex JW Sharp, CM Ross‐Inta, I Baccelli, JA Payne, JB Rudell, DW Gietzen Journal of neurochemistry 127 (4), 520-530, 2013 | 6 | 2013 |
| Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia J Krosl, ME Bordeleau, C Moison, T MacRae, I Boivin, N Mayotte, ... Blood Advances 6 (2), 509-514, 2022 | 4 | 2022 |
| The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis L Lenk, I Baccelli, A Laqua, J Heymann, C Reimer, A Dietterle, ... Blood 143 (26), 2735-2748, 2024 | 3 | 2024 |
| CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury C Ligeron, J Saenz, B Evrard, M Drouin, E Merieau, C Mary, K Biteau, ... The Journal of Immunology 212 (7), 1178-1187, 2024 | 2 | 2024 |
| Mubritinib targets the electron transport chain complex I and reveals the landscape of mitochondrial vulnerability in acute myeloid leukemia I Baccelli, Y Gareau, B Lehnertz, G Stephane, JF Spinella, A Beautrait, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 2 | 2018 |
